Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.
Starr, T.N., Greaney, A.J., Hannon, W.W., Loes, A.N., Hauser, K., Dillen, J.R., Ferri, E., Farrell, A.G., Dadonaite, B., McCallum, M., Matreyek, K.A., Corti, D., Veesler, D., Snell, G., Bloom, J.D.(2022) Science 377: 420-424
- PubMed: 35762884 
- DOI: 10.1126/science.abo7896
- Primary Citation of Related Structures:  
8DF5 - PubMed Abstract: 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved variants with substitutions in the spike receptor-binding domain (RBD) that affect its affinity for angiotensin-converting enzyme 2 (ACE2) receptor and recognition by antibodies. These substitutions could also shape future evolution by modulating the effects of mutations at other sites-a phenomenon called epistasis ...